Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
Observational Study of the Rhinopharyngeal Carriage of Streptococcus Pneumoniae (Sp) in Infants With Acute Otitis Media (AOM)
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Listed as NCT00195611, this observational or N/A phase trial focuses on Otitis Media and Otitis Media With Effusion and remains completed. Sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, it has been updated 8 times since 2005, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Jan 2026 — Present [monthly]
Completed
-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: PHASE4 → None
-
Jan 2017 — Apr 2018 [monthly]
Completed PHASE4
First recorded
Sep 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Wyeth is now a wholly owned subsidiary of Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Auch, France , Brest, France , Canne La Boca, France , Chambéry, France , Châlons-en-Champagne, France , Combs-la-Ville, France , Créteil, France , Draguignan, France , Essey-lès-Nancy, France , Fontenay-sous-Bois, France and 21 more locations